It may still be under production, but Apple’s HealthKit is slated to star in two chronic disease management trials being launched in the near future.

As reported by Reuters, Stanford University Hospital will be using the mHealth platform to connect diabetic children with physicians tracking their blood sugar levels. Duke University, meanwhile, will be using the platform to enable physicians to track blood pressure, weight and other physiological data in patients who have been diagnosed with heart disease or cancer.

“This could eliminate the hassle of getting data from patients, who want to give it to us,” Ricky Bloomfield, an internal medicine pediatrician and director of mobile strategy, told Reuters. “HealthKit removes some of the error from patients’ manually entering their data.”

The two projects mark the first known tests of HealthKit, which Apple has for the most part kept under wraps. As envisioned, the platform would gather data from regulated medical devices, such as blood glucose monitors, blood pressure cuffs and weight scales, and share the data with clinicians, with the patient’s consent.

According to the Reuters article, Stanford and Duke are “among the furthest along” of a group of hospitals working with Apple to test HealthKit.

At Stanford, young patients with type 1 diabetes will monitor their blood sugar levels in between doctor’s visits with an iPod Touch. The device will be used to grab blood sugar readings from DexCom sensors positioned just beneath the skin of the abdomen, which continuously monitor blood sugar and transmit readings every five minutes to a handheld receiver. HealthKit would then send that data to the “MyChart” application in Stanford’s Epic electronic medical record.

Little information was available on the Duke project, and Apple officials wouldn’t offer any comments, Reuters reported.

Related articles: 

Vicious circle: IT sets BYOD and social media parameters, users disagree

mHealth masters: Harry Greenspun on the promise of applied analytics


No comments

Be the first one to leave a comment.

Post a Comment